Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial
| Status: | Recruiting |
|---|---|
| Conditions: | Post-Surgical Pain |
| Therapuetic Areas: | Musculoskeletal |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/3/2019 |
| Start Date: | December 30, 2018 |
| End Date: | December 2019 |
| Contact: | Greg J Haro, MD |
| Email: | greg.haro@ucsf.edu |
| Phone: | 415-353-8196 |
Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial - Liposomal Bupivacaine Versus Standard Bupivacaine
The Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial is a single center,
double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic
efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in
subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.
double-blind, randomized, active-comparator controlled clinical trial to assess the analgesic
efficacy of intercostal nerve block by Liposomal Bupivacaine versus Standard Bupivacaine in
subjects undergoing lung resection by robotic or video-assisted thoracoscopic surgery.
Inclusion Criteria:
- Robotic or Video-Assisted Lung Resection for All Indications
Exclusion Criteria:
- Additional Thoracic Procedures (beyond lung resection and mediastinal lymphadenectomy)
- Extra-Thoracic Procedures
- Hypersensitivity to Amide Local Analgesia
- Cardiac Conduction Abnormalities
- Hepatic Dysfunction
- Preoperative Neuropathic Pain and/or Preoperative Daily Opioid Usage
We found this trial at
1
site
Click here to add this to my saved trials
